PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ZBH vs. ^IXIC
Performance
Risk-Adjusted Performance
Drawdowns
Volatility

Correlation

The correlation between ZBH and ^IXIC is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

ZBH vs. ^IXIC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zimmer Biomet Holdings, Inc. (ZBH) and NASDAQ Composite (^IXIC). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-0.25%
9.01%
ZBH
^IXIC

Key characteristics

Sharpe Ratio

ZBH:

-0.44

^IXIC:

1.75

Sortino Ratio

ZBH:

-0.48

^IXIC:

2.31

Omega Ratio

ZBH:

0.94

^IXIC:

1.31

Calmar Ratio

ZBH:

-0.24

^IXIC:

2.44

Martin Ratio

ZBH:

-0.64

^IXIC:

8.82

Ulcer Index

ZBH:

15.01%

^IXIC:

3.64%

Daily Std Dev

ZBH:

21.72%

^IXIC:

18.34%

Max Drawdown

ZBH:

-65.03%

^IXIC:

-77.93%

Current Drawdown

ZBH:

-34.87%

^IXIC:

-2.70%

Returns By Period

In the year-to-date period, ZBH achieves a 3.72% return, which is significantly higher than ^IXIC's 1.65% return. Over the past 10 years, ZBH has underperformed ^IXIC with an annualized return of 0.45%, while ^IXIC has yielded a comparatively higher 15.28% annualized return.


ZBH

YTD

3.72%

1M

2.51%

6M

-0.25%

1Y

-10.42%

5Y*

-4.92%

10Y*

0.45%

^IXIC

YTD

1.65%

1M

0.29%

6M

9.01%

1Y

28.21%

5Y*

15.98%

10Y*

15.28%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ZBH vs. ^IXIC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZBH
The Risk-Adjusted Performance Rank of ZBH is 2525
Overall Rank
The Sharpe Ratio Rank of ZBH is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of ZBH is 2020
Sortino Ratio Rank
The Omega Ratio Rank of ZBH is 2020
Omega Ratio Rank
The Calmar Ratio Rank of ZBH is 3131
Calmar Ratio Rank
The Martin Ratio Rank of ZBH is 3333
Martin Ratio Rank

^IXIC
The Risk-Adjusted Performance Rank of ^IXIC is 7777
Overall Rank
The Sharpe Ratio Rank of ^IXIC is 7575
Sharpe Ratio Rank
The Sortino Ratio Rank of ^IXIC is 7575
Sortino Ratio Rank
The Omega Ratio Rank of ^IXIC is 7777
Omega Ratio Rank
The Calmar Ratio Rank of ^IXIC is 7777
Calmar Ratio Rank
The Martin Ratio Rank of ^IXIC is 7979
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ZBH vs. ^IXIC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and NASDAQ Composite (^IXIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ZBH, currently valued at -0.44, compared to the broader market-2.000.002.004.00-0.441.75
The chart of Sortino ratio for ZBH, currently valued at -0.48, compared to the broader market-4.00-2.000.002.004.006.00-0.482.31
The chart of Omega ratio for ZBH, currently valued at 0.94, compared to the broader market0.501.001.502.000.941.31
The chart of Calmar ratio for ZBH, currently valued at -0.24, compared to the broader market0.002.004.006.00-0.242.44
The chart of Martin ratio for ZBH, currently valued at -0.64, compared to the broader market-10.000.0010.0020.0030.00-0.648.82
ZBH
^IXIC

The current ZBH Sharpe Ratio is -0.44, which is lower than the ^IXIC Sharpe Ratio of 1.75. The chart below compares the historical Sharpe Ratios of ZBH and ^IXIC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
-0.44
1.75
ZBH
^IXIC

Drawdowns

ZBH vs. ^IXIC - Drawdown Comparison

The maximum ZBH drawdown since its inception was -65.03%, smaller than the maximum ^IXIC drawdown of -77.93%. Use the drawdown chart below to compare losses from any high point for ZBH and ^IXIC. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-34.87%
-2.70%
ZBH
^IXIC

Volatility

ZBH vs. ^IXIC - Volatility Comparison

The current volatility for Zimmer Biomet Holdings, Inc. (ZBH) is 5.73%, while NASDAQ Composite (^IXIC) has a volatility of 6.58%. This indicates that ZBH experiences smaller price fluctuations and is considered to be less risky than ^IXIC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%AugustSeptemberOctoberNovemberDecember2025
5.73%
6.58%
ZBH
^IXIC
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab